The FDA based its approval on results from a clinical trial programme involving over 1,600 patients
Log in met Medi-Access
Wilt u het gehele artikel lezen?
Log in met Medi-Access om verder te lezen
Pfizer’s Cibinqo granted FDA approval for adults with moderate-to-severe atopic dermatitis
PMLiVE | Geplaatst op 17.01.2022 14:32